🔗 Share this article TikTok Influencers Driving Unofficial Trade for Unapproved Weight-Loss Drug An underground market for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations. Experimental Drug Acquiring Traction Via Social Media Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these profiles privately for supplier links, while also obtaining discount codes. Thriving Commerce on Messaging Platforms Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to other platforms for transactions. Understanding Retatrutide Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic. Healthcare Experts Voice Concerns However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin. Several experts said the demand for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro. Legal Position and Implementation Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations. Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment. Service Reaction and Material Removal Based on TikTok, the service has taken down violative material and prohibited associated keywords and query recommendations. The company stated it was committed to keeping the platform secure and allocating resources in strengthening compliance measures. Online Trading Activities Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of users, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or administering at residence. Within minutes of joining one community, a vendor posted WhatsApp details, where most purchases occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, health issues or previous experience. Product Information and Costs Within these communities, posts show black plastic packages with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.” Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When questioned how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”. Service Oversight and Safety Actions A spokesperson for Telegram said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Healthcare Expert Warnings “People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U. A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained. Her team has previously seen patients injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.” Manufacturer Statement A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to potentially serious medical dangers”.